ArticleCancer immunology, immunotherapy : CII2004

Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes.

Frank Neumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.